Stock Compensation Information (Tables)

9 Months Ended

Jan. 31, 2013

Stock Compensation Information [Abstract]

Schedule Of Equity-Based Compensation Expense From Operations

		Three Months Ended				Nine Months Ended
		January 31,				January 31,
		2013		2012		2013		2012
Direct costs of revenue	$	9	$	17	$	27	$	55
Product development		21		37		70		116
Selling, general and administrative		131		176		395		533
Total equity-based compensation	$	161	$	230	$	492	$	704

Summary Of Remaining Unrecognized Compensation Expense

Fiscal Year Ending April 30,		Amount
Remainder of 2013	$	102
2014		249
2015		147
2016		59
2017		3
Total	$	560

Summary Of Fair Value Assumptions

		Nine Months Ended
		January 31,
		2013		2012
Expected term (in years)		4.0		4.0
Risk-free interest rate		0.5	%	1.1	%
Volatility		77	%	89	%
Dividend yield		-		-
Weighted-average fair value of stock options granted during the year	$	1.01	$	2.38

Summary Of Stock Option Activity

			Weighted-	Weighted-
			average	average remaining		Aggregate
			exercise	contractual		intrinsic
	Shares		price	term (in years)		value (1)
Outstanding at April 30, 2012	2,632,115	$	3.18	7.24	$	4,449
Granted	398,500		1.27
Exercised	-		-
Cancelled/expired	(673,145)		2.66
Outstanding at January 31, 2013	2,357,470	$	3.00	6.86	$	23,557

(1) Aggregate intrinsic value is defined as the difference between the current market value and the exercise price and is estimated using the closing price of the Company’s common stock on the last trading day of the periods ended as of the dates indicated.

Summary Of Non-Vested Stock Option Activity

			Weighted-
			average
			grant date
	Shares		fair value
Nonvested at April 30, 2012	1,005,036	$	1.61
Granted	398,500		1.01
Vested	(406,783)		1.52
Cancelled/expired	(430,517)		1.50
Nonvested at January 31, 2013	566,236		1.32